tiprankstipranks
Trending News
More News >

Nihon Chouzai Announces Corrections to Financial Results

Story Highlights
  • Nihon Chouzai operates in healthcare, focusing on pharmacy services and pharmaceutical sales.
  • The company corrected financial results due to errors, impacting segment-related data.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Nihon Chouzai Announces Corrections to Financial Results

Don’t Miss TipRanks’ Half-Year Sale

Nihon Chouzai Co ( (JP:3341) ) just unveiled an update.

Nihon Chouzai Co., Ltd. announced corrections to its consolidated financial results for the fiscal year ending March 31, 2025, due to errors found during the preparation of their Annual Securities Report. These corrections primarily affect segment-related financial data, including net sales, segment profit, and asset adjustments, which are crucial for stakeholders to assess the company’s financial health and operational efficiency.

More about Nihon Chouzai Co

Nihon Chouzai Co., Ltd. operates in the healthcare sector, focusing on dispensing pharmacy services, pharmaceutical manufacturing and sales, and medical professional staffing and placement. The company is listed on the Tokyo Stock Exchange Prime Market.

Average Trading Volume: 315,224

Technical Sentiment Signal: Buy

Current Market Cap: Yen93.63B

Learn more about 3341 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1